Science News & Science Current Events
 
Email a Friend Send to a friend
Printer Friendly Print Study offers window into human behavior, brain disease

Study offers window into human behavior, brain disease

December 26, 2006

UCSF scientists have identified a cell population that is a primary target of the degenerative brain disease known as frontotemporal dementia, which is as common as Alzheimer's disease in patients who develop dementia before age 65.

Because the cells arose only recently in evolutionary history - in a common ancestor of great apes and humans- and are particularly abundant in humans, and the finding supports the concept that evolution has rendered the human brain vulnerable to disease, including frontotemporal dementia, and, possibly, disorders such as autism and schizophrenia, the researchers say.




In addition, because the disease erodes aspects of social behavior and emotions - self awareness, moral reasoning and empathy - that are highly developed in humans, the finding suggests that the cells may play a role in what makes humans "human," they say.

The finding is reported in the December 22 on-line issue of Annals of Neurology.

The cells, known as von Economo neurons, were first comprehensively described in 1925 by their Romanian-Austrian namesake, who determined that the unusually shaped cells - large, cigar-shaped and tapered at each end, with only a few dendritic processes extending away from them - were localized in only two regions of the frontal lobes.

The cells received only limited attention in the ensuing years, but in the meantime scientists determined that the brain regions in which von Economo neurons arise - the anterior cingulate and frontoinsular cortex - are key targets of frontotemporal dementia. And in 1999, a team of U.S. scientists made the surprising discovery that, among primates, von Economo neurons were seen only in great apes and humans.

In the current study, the UCSF team set out to explore whether von Economo neurons could be the target of FTD.

Working in the laboratory of senior author Stephen J. DeArmond, MD, PhD, UCSF professor of pathology, they compared the numbers of von Economo neurons and neighboring neurons in the anterior cingulate cortex, looking specifically at brain tissue from three sets of deceased patients - seven who had no neurological disease, five who had Alzheimer's disease and seven who had frontotemporal dementia.

The results were striking. In frontotemporal dementia, there was early, severe and selective loss of von Economo neurons compared to control subjects. In Alzheimer's disease, von Economo neurons were not significantly depleted.

"This finding provides new insight into how frontotemporal dementia erodes the brain at the cellular level," says the first author of the study, William Seeley, MD, UCSF instructor of neurology and a clinician-scientist at the UCSF Memory and Aging Center.

Progress has been made in illuminating some of the genetic and molecular aspects of the disease - two mutated genes are associated with most inherited forms of the disease and major misprocessed proteins have been identified - but "discoveries at the genetic and molecular level do not yet explain why specific populations of neurons are dying," he says.

"This observation gives us a new window into the early and cell-specific degenerative process, and we can use this window to better understand disease pathogenesis."

The team, led by Seeley, is currently trying to study von Economo neuron-rich regions in living patients using neuroimaging. They also are studying VENs, themselves, in autopsy studies using neuropathological techniques.

As FTD is a disease for which there is as yet no disease-modifying therapy, studies of von Economo neurons could provide new strategies.

Why the cells are vulnerable is still a mystery, says Seeley. But given the fact that they are evolutionarily new, the explanation may be that there are still "kinks" in the genetic programming of the neuronal circuits.

"VENs probably help us in some wonderful way, which would explain why natural selection has pushed their rapid evolution in humans," he says. "Still, in the context of FTD, something about VENs makes them vulnerable."

Notably, cell-specific degeneration is a unifying feature of all the neurodegenerative diseases. Dopamine-producing neurons in the substantia nigra region of the brain deteriorate in Parkinson's disease, motor neurons of the spinal cord and motor cortex degenerate in ALS and specific memory-forming medial temporal lobe neurons die in early Alzheimer's disease.

"We hope to add von Economo neurons to that list," says Seeley. "It's a pretty important list to fill in, but for FTD there just hasn't been a good candidate until now. We think we've found it, and that is the most exciting part of the discovery for those of us who treat patients."

At the same time, he says, the finding "gives us a sense that we might be able to start to figure out what makes us unique as humans, what makes our brains different from those of other species. And that's pretty exciting, too."

Bruce Miller, MD, the A.W. & Mary Margaret Clausen Distinguished Professor of Neurology, director of the UCSF Memory and Aging Center and a co-author of the study, concurs.

"The social and behavioral skills that you lose in frontotemporal dementia are so characteristically human, or at least strongly associated with higher primates," he reflects.

"I think it's fascinating from an evolutionary perspective that we have these new neurons that are involved in social behavior that are selectively vulnerable in the second major degenerative disorder."

Notably, VENs are located in regions of the brain that are in a good position to transmit raw emotional signals to other brain centers. In addition, VENs have characteristics that suggest they play a role in analyzing sparse inputs and sending rapid output signals, further supporting the idea that they may impact behavior.

It's possible, says Seeley, that scientists will be able to figure out what these neurons normally do. But it won't be easy.

"These are such abstract brain capacities we're talking about"¦It's not like analyzing movement of your right arm or color vision. We're talking about understanding how we read others' minds. The philosopher in me sees the opportunity to really learn something interesting about human nature, here."

Still, he says, "It's the neurologist in me that brings me to work everyday, and as a neurologist what I want is to help cure the disease."

University of California - San Francisco



Related Brain Disease Current Events and Brain Disease News Articles Brain Disease Current Events and Brain Disease News RSS Brain Disease Current Events and Brain Disease News RSS
Milestone for cannabinoid MS study
The CUPID (Cannabinoid Use in Progressive Inflammatory brain Disease) study at the Peninsula Medical School in Plymouth has reached an important milestone with the news that the full cohort of 493 people with multiple sclerosis (MS) has been recruited to the study.

New 'everyday cognition' scale tracks how older adults function in daily life
As more adults age into the high-risk period for cognitive impairment, clinicians need simple and reliable methods to identify where they may have problems in everyday life that reveal underlying changes in the brain.

Discovery will assist treatment and research into fatal brain disorder
Research using newly developed Magnetic Resonance Imaging technology could soon allow clinicians to confirm Huntington's disease before symptoms appear in people who have the gene for the fatal brain disease.

Molecular imaging sheds new light on progression of Alzheimer's disease
In the past, physicians were able only to follow the progression of Alzheimer's disease (AD) through careful clinical histories, noting the often subtle changes associated with cognitive decline over a number of years.

Sleeping sickness finding could lead to earlier diagnosis
Sleeping sickness creates a metabolic 'fingerprint' in the blood and urine, which could enable a new test to be developed to diagnose the disease, according to new research published today in the journal Proceedings of the National Academy of Sciences.

1/3 of risk for dementia attributable to small vessel disease, autopsy study shows
Alzheimer's disease may be what most people fear as they grow older, but autopsy data from a long-range study of 3,400 men and women in the Seattle region found that the brains of a third of those who had become demented before death showed evidence of small vessel damage: the type of small, cumulative injury that can come from hypertension or diabetes.

New Research Shows Benefits of Ultrasound Contrast Agents Outweigh Potential Risk to Heart Patients
ST. LOUIS - A Saint Louis University cardiologist called upon the U.S. Food and Drug Administration (FDA) on Monday to reconsider a strong warning it recently placed on a diagnostic tool, stating that the warning could prevent doctors from detecting life-threatening cardiac events.

PET's Targeted Imaging May Lead to Earlier, More Accurate Diagnosis of Dementia and Alzheimer's Disease
Researchers involved in a large, multi-institutional study using positron emission tomography (PET) imaging with the radiotracer fluorodeoxyglucose (FDG) were able to classify different types of dementia with very high rates of success, raising hopes that dementia diagnoses may one day be made at earlier stages.

Surgery Improves Quality of Life for Children with Sleep Apnea, SLU Study Finds
For children who suffer from obstructive sleep apnea (OSA), a tonsillectomy and adenoidectomy can provide dramatic relief and is successful in solving sleep problems for 80 to 90 percent of children, a Saint Louis University study found.

Treating Acne: Two Different Peels Both Effective, SLU Study Finds
Chemical peels using either alpha-hydroxy acid or beta-hydroxy acid are both highly effective in treating mild to moderately severe facial acne, researchers at the Saint Louis University School of Medicine have found - the first study to compare the two different types of acid peels as therapies for the skin disorder.
More Brain Disease Current Events and Brain Disease News Articles


Making the Connection Between Brain and Behavior: Coping with Parkinson's Disease
by Joseph H. Friedman

While patients and families are aware of the physical challenges that accompany Parkinson’s disease, few are prepared for the common behavioral issues that impact their quality of life, including depression, anxiety, dementia, paranoid delusions, and sleep disorders. This book, the only one of its kind, focuses entirely on an area that most doctors overlook. Written in layman’s terms, it...

The Neuropsychology of Degenerative Brain Diseases
by Robert G. Knight

This volume utilizes various neurological diseases as its organizing principle, focusing specifically on their personal, social, and cognitive consequences. In so doing, it provides neuropsychologists, clinical psychologists, and those in related disciplines with an accessible survey of the available research on the psychological functioning of patients with the various disorders. Each chapter...



Brain Tumors (Diseases and Disorders)
by Arda Darakjian Clark

Brain tumors, both benign and malignant, present severe challenges to patients, their families, and to the medical professionals who treat them. This book discusses symptoms and diagnosis of brain tumors, standard and experimental treatments, and the need for care and rehabilitation following treatment....



If I Only Had a Brain Injury
by Laura Bruno

"If I Only Had a Brain Injury is a page-turner and a must-read. It is a testimony of the power of believing in oneself, a true survival story." --Alina Oswald "The 'Oz' analogy is something I had never thought of and it is perfect. ... The book will be a great resource. ... I especially like that you offer ways to deal with the emotional impact on survivors, friends and family members....



The Brain Wash: A Powerful, All-Natural Program to Protect Your Brain Against Alzheimer's, Chronic Fatigue Syndrome, Depression, Parkinson's, and Other Diseases
by Michelle Schoffro Cook

A Powerful, All-Natural Program to Protect Your Brain Against Alzheimer's, Chronic Fatigue Syndrome, Depression, Parkinson's, and Other Brain Diseases. Scientists predict that within fifteen years brain disease will kill or disable more North Americans than cancer and heart disease combined. The Brain Wash is a powerful, holistic health plan based on the most cutting-edge brain,...



Beating Alzheimer's: A Step Towards Unlocking the Mysteries of Brain Diseases
by Tom Warren

Mri of the Brain II: Non-Neoplastic Disease (Raven Mri Teaching File Series)
by Michael Brant-Zawadyzki

This volume of the Raven MRI Teaching File set is a uniquely practical guide to interpreting magnetic resonance images of non-neoplastic diseases of the brain, particularly hydrocephalus, infarction, and demyelinating disease. It contains 100 actual completed case studies, each two to four pages in length and illustrated with high-resolution MR images selected on the basis of clinical...



Deep Brain Stimulation for Parkinson's Disease (Neurological Disease and Therapy)

Considered the largest breakthrough in the treatment of Parkinson’s disease in the past 40 years, Deep Brain Stimulation (DBS) is a pioneering procedure of neurology and functional neurosurgery, forging enormous change and growth within the field. The first comprehensive text devoted to this surgical therapy, this source expertly examines all aspects of DBS from history and theory to patient...



Brain Storms: Surviving Catastrophic Illness
by Les Duncan



Best Practices in the Behavioral Management of Chronic Disease, Volume I: Neuropsychiatric Disorders

Best Practices provides review of evidence-based practices for managing chronic mental health conditions by changing behavior. Chapters review and summarize research, present effective interventions for some of the most common chronic conditions, and identify important unanswered questions concerning management of these chronic disorders. Chapters are written by leading researchers or clinicians...

© 2008 BrightSurf.com